𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disruption of the blood–brain barrier following ALA-mediated photodynamic therapy

✍ Scribed by Henry Hirschberg; Francisco A. Uzal; David Chighvinadze; Michelle J. Zhang; Qian Peng; Steen J. Madsen


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
197 KB
Volume
40
Category
Article
ISSN
0196-8092

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effects of ALA-mediated photodynamic the
✍ Henry Hirschberg; Chung-Ho Sun; Tatiana Krasieva; Steen J. Madsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Background and Objective: High-grade gliomas are characterized by rapid proliferation, angiogenesis, and invasive growth. Eradication or inhibition of infiltrating glioma cells poses a significant clinical challenge that is unlikely to be solved using conventional treatment regimens consisting of io

Study of the efficacy of 5-ALA mediated
✍ M. Atif; M. Fakhar-e-Alam; S. Firdous; S.S.Z. Zaidi; R. Suleman; M. Ikram 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

The aim of this study was to investigate the mechanism of cell death by photodynamic therapy (PDT) in the Rhabdomyosarcoma (RD) cell line. The present study evaluates the effects of photodynamic therapy (PDT) with 5-ALA as photosensitizer using human muscle cancer cells as experimental model. We stu

Disruption of the blood-brain barrier in
✍ E. S. Sears; D. W. McCandless; M. D. Chandler 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

Both hyperammonemia and blood-brain barrier (BBB) breakdown have been implicated in the evolution of hepatic encephalopathy. To define a possible relationship, Swiss Albino mice were subjected to sublethal encephalopathic doses of ammonium acetate; the integrity of the BBB was determined grossly wit

Enhanced chemotherapy delivery by intraa
✍ David Fortin; Cathy Gendron; Marie Boudrias; Marie-Pierre Garant 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

## Abstract ## BACKGROUND. Cerebral metastases are clinically significant in 10% to 30% of patients with neoplasia. Multiple cerebral metastases are typically treated with palliative radiotherapy. There is no consensus on the role of enhanced chemotherapy delivery as an adjuvant treatment modality